Events for May 3, 2024

Please join us for a special discussion on the development, manufacturing, and analysis of DNA & RNA therapeutics utilizing both cell-based and cell-free processes. This includes the raw materials necessary for in vitro replication and/or transcription with a focus on the acquisition of high-quality nucleotides and recombinant enzymes. The meeting will also consider drug product formulations and nanoparticle delivery systems, including the associated raw materials, with lipids as a particular focus.

Industry experts will share their knowledge and we will present and discuss how to optimize technologies and process setups, manufacturing challenges, and strategies such as digitalization, modelling, automation, scaling up, single-use technology, and securing process continuity. Case studies will also be presented in this track. Attend the cell and gene therapy track to learn about the future of cell and gene therapy bioprocessing. The track includes expert talks on the considerations around manufacturing ATMPs, from closed loop systems for cell therapy to decentralized sites. We also cover the technical aspects of how to optimize AAV manufacturing, tackling increased demand for viral and non-viral vectors, and developing the next generation of vectors.